Dabidane
Anticoagulant indicated for the prevention of cerebrovascular accident and systemic embolism and for mortality reduction in patients with non-valvular atrial fibrillation.
Therapeutic Area
Anticoagulant
Active Ingredient
Dabigatrán
Line
Cardiometabolism
Pharmaceutical Forms
75 mg capsules x 30
110 mg capsules x 30
110 mg capsules x 60
150 mg capsules x 30
150 mg capsules x 60
